Myocardial hypertrophy in transgenic mice overexpressing the bovine growth, hormone (bGH) gene

Journal of Internal Medicine

Volumn 247, Issue 5, 2000, Pages 546-552

  Fu, Michael L X ^a   Tornell J ^b   Schulze, W ^c   Hoebeke, J ^c   Isaksson, O G P ^d   Sandstedt, J ^b   Hjalmarson, A ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Growth hormone; Heart; Receptor; Structure; Transgenic mice

Indexed keywords

BETA ADRENERGIC RECEPTOR; GROWTH HORMONE; MUSCARINIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MOUSE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; TRANSGENIC MOUSE;

ANIMALS; BINDING, COMPETITIVE; CARDIOMEGALY; CATTLE; GENE EXPRESSION; GROWTH HORMONE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MYOCARDIUM; RADIOIMMUNOASSAY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC;

EID: 0034072238     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00651.x     Document Type: Article

References (24)

1. 1 Sönksen PH. Replacement therapy in hypothalmopituitary insufficiency after childhood: management in the adult. Horm Res 1990; 33: 45-51.
2. 2 Shahi M, Beshyah SA, Hackett D, Sharp P, Johnston DG, Foale R. Myocardial function in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 1992; 67: 92-96.
3. 3 Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R, Johnston DG. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol 1994; 130: 451-58.
4. 4 Rosén T, Bengtsson BÅ. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-88.
5. 5 Cuneo RC, Salomon F, Wilmshurst P et al. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci 1991; 81: 587-92.
6. 6 Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 1995; 80: 659-66.
7. 7 Courville C, Mason VR. The heart in acromegaly. Arch Intern Med 1938; 61: 704-13.
8. 8 Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995; 92: 262-67.
9. 9 Fazio S, Sabatini D, Capaldo B et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Eng J Med 1996; 334: 856-57.
10. 10 Hogan B, Constantini F, Lacy E. Manipulating the Mouse Embryo - A Laboratory Manual. Cold Spring Habor, USA: Cold Spring Harbor Laboratory, 1986.
11. 11 Lund DD, Tomanek RJ. Myocardial morphology in spontaneously hypertensive and aortic-constricted rats. Am J Anat 1978; 152: 141-52.
12. 12 Weibel ER. Stereological Methods for Biological Morphometry. London: Academic press, 1979.
13. 13 McPherson GA. Kinetic, EBDA, Ligand, Lowry (Manual). Amsterdam, the Netherlands: Elsevier Biosoft 1985.
14. 14 Lowry DH, Rosebrough DJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
15. 15 Penney DG, Dunbar JC Jr. Baylerian MS. Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumor. Cardiovas Res 1985; 19: 270-77.
16. 16 Rubin SA, Buttrick P, Malhotra A, Melmed S, Fishbein MC. Cardiac physiology, biochemistry and morphology in response to excess growth hormone in the rat. J Mol Cell Cardiol 1990; 22: 429-38.
17. 17 Prysor-Jones RA, Jenkins JS. Fffect of excessive secretion of growth hormone on tissues of the rat, with particular reference to the heart and skeletal muscle. J Endocrinol 1980; 85: 75-82.
18. 18 Gilbert PL, Siegel RJ, Melmed S, Sherman CT, Fishbein MC. Cardiac morphology in rats with growth hormone-producing tumors. J Mol Cell Cardiol 1985; 17: 805-11.
19. 19 Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol 1995; 80: 552-57.
20. 20 Beshyah SA, Shahi M, Foale R, Johnston DG. Cardiovascular effects of prolonged growth hormone replacement in adults. J Intern Med 1995; 237: 35-42.
21. 21 Guron G, Friberg P, Wickman A, Brantsing C, Gabrielsson B, Isgaard J. Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension. Hypertension 1996; 27: 636-42.
22. 22 Isgaard J, Wahlander H, Adams MA, Friberg P. Increased expression of growth hormone receptor mRNA and insulin-like growth factor-1 mRNA in volume-overloaded hearts. Hypertension 1994; 23: 884-88.
23. 23 Timsit J, Riou B, Bertherat J et al. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricles. J Clin Invest 1990; 86: 507-15.
24. + current in ventricular myocytes from acromegalic rats. Am J Physiol 1991; 260: H935-42.